Molbio Diagnostics, in a strategic move, has joined forces with Bangalore-based deep-tech startup Niramai Health Analytix to propel the global deployment of Niramai's revolutionary AI-driven breast cancer screening solution, Thermalytix, across developing nations.

The collaboration introduces Thermalytix, a non-invasive breast cancer screening solution utilizing thermal scanning fused with intelligent AI-powered software. This cutting-edge technology detects early indications of breast cancer that might otherwise elude detection through conventional methods. Notably, Thermalytix facilitates non-contact screening, addressing privacy concerns and overcoming reluctance for breast examinations. Additionally, the imaging technique is radiation-free, painless, and adaptable for diverse age groups, including young women with dense breasts.

Molbio's role in this partnership involves advocating for and distributing Thermalytix within global public and private healthcare markets. By leveraging the strengths of both entities, the collaboration aims to democratize high-quality diagnostics, making them universally accessible.

Sriram Natarajan, Vice President of Sales & Marketing at Molbio, expressed enthusiasm about augmenting their array of innovative healthcare solutions. He emphasized the potential of Niramai's AI-powered Thermalytix and Molbio's Truenat HPV-HR test for cervical cancer to revolutionize point-of-care screening, enabling early detection of two of the most fatal cancers affecting women worldwide.

Dr. Geetha Manjunath, Founder and CEO of Niramai Health Analytix, underscored the collaboration's transformative impact, highlighting its ability to extend an affordable and automated breast screening test to women worldwide. She emphasized the partnership's role in enhancing health equity by making advanced breast cancer screening accessible to all.

The alliance between Molbio Diagnostics and Niramai Health Analytix signifies a milestone in advancing global healthcare. This partnership aims to bring forth innovative diagnostic solutions, reshaping the landscape of breast cancer screening and potentially saving countless lives worldwide.